Skip to content

Gjalt W. Huisman

Chief Executive Officer at Embold Therapeutics.

Raised on Embold Therapeutics filings

$2.5M

of $5M offered across 1 Form D filing

Form D filings
1
Teammates
1
Last filing
Jul 24, 2026

Company

Embold Therapeutics

Biotech · Redwood City, CA

Engineered enzyme therapy for genetic Parkinson's disease

Investors
7
Founded
2023
Still open
$2.5M

Embold Therapeutics filings

  • Security to be acquiredFiled Jul 24, 2026Form D/A
    $2.5M/ $5M

Works with